KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) FCF Margin: 2009-2025

Historic FCF Margin for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Sep 2025 value amounting to 42.15%.

  • Jazz Pharmaceuticals' FCF Margin rose 537.00% to 42.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.49%, marking a year-over-year decrease of 1581.00%. This contributed to the annual value of 33.37% for FY2024, which is 552.00% up from last year.
  • Per Jazz Pharmaceuticals' latest filing, its FCF Margin stood at 42.15% for Q3 2025, which was up 150.10% from -84.13% recorded in Q2 2025.
  • Jazz Pharmaceuticals' FCF Margin's 5-year high stood at 46.55% during Q1 2021, with a 5-year trough of -84.13% in Q2 2025.
  • Its 3-year average for FCF Margin is 20.33%, with a median of 31.41% in 2023.
  • Per our database at Business Quant, Jazz Pharmaceuticals' FCF Margin surged by 2,658bps in 2022 and then tumbled by 11,580bps in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' FCF Margin (Quarterly) stood at 18.71% in 2021, then skyrocketed by 1,550bps to 34.21% in 2022, then tumbled by 1,867bps to 15.54% in 2023, then spiked by 1,987bps to 35.41% in 2024, then surged by 537bps to 42.15% in 2025.
  • Its last three reported values are 42.15% in Q3 2025, -84.13% for Q2 2025, and 35.41% during Q4 2024.